AF
AURA icon

Allworth Financial’s Aura Biosciences AURA Stock Holding History

Allworth Financial’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56K Sell
502
-243
-33% -$1.74K ﹤0.01% 4293
2026
Q1 		$4.99K Buy
745
+632
+559% +$3.63K ﹤0.01% 3963
2025
Q4 		$616 Buy
113
+55
+95% +$327 ﹤0.01% 4481
2025
Q3 		$359 Sell
58
-203
-78% -$1.33K ﹤0.01% 4514
2025
Q2 		$1.63K Buy
261
+195
+295% +$1.14K ﹤0.01% 3794
2025
Q1 		$365 Buy
66
+22
+50% +$166 ﹤0.01% 3759
2024
Q4 		$349 Buy
+44
New +$414 ﹤0.01% 3681

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Allworth Financial's AURA Position: Q2 2026 in Review

Allworth Financial reduced its Aura Biosciences (AURA) stake by 33% in Q2 2026, selling an estimated $1.74K and leaving 502 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #4293.

Allworth Financial first reported a position in AURA in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.99K in Q1 2026. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Allworth Financial held 502 shares of Aura Biosciences worth $3.56K as of Q2 2026.
  • Allworth Financial sold 243 Aura Biosciences shares in Q2 2026, an estimated $1.74K.
  • Aura Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4293 holding.
  • Allworth Financial first reported a position in Aura Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Allworth Financial's Aura Biosciences position peaked at $4.99K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.